Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on February 2, 2023


NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter of 2022 on Thursday, February 2, 2023. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 9:00 a.m. ET on the same date.

Investors and the general public are invited to listen to a live webcast of the call at Investors and the public can also access the live conference call by dialing in the U.S. toll free 888-300-3045 or international +1 646-568-1027, conference code: 3734085. Materials related to the call will be available at prior to the start of the conference call.

A replay of the webcast will be available on approximately three hours after the conference call concludes. A replay of the conference call will be available beginning at 11:30 a.m. ET on February 2 through 11:30 a.m. ET on February 16, 2023, by dialing in the U.S. toll free 800-770-2030 or international +1 647-362-9199, conference code: 3734085.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.




Source: Bristol Myers Squibb

Back to news